Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 26, 2022
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
[ Tue, Jul 26th 2022
] - WOPRAI
Do Kim Maintained (TVTX) at Buy with Increased Target to $41 on, Jul 26th, 2022
Do Kim of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Increased Target from $40 to $41 on, Jul 26th, 2022.
Do has made no other calls on TVTX in the last 4 months.
There are 2 other peers that have a rating on TVTX. Out of the 2 peers that are also analyzing TVTX, 0 agree with Do's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Do
- Edward Nash of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $42 on, Thursday, July 14th, 2022
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $46 on, Tuesday, May 17th, 2022
